Parkinson's disease is a common neurodegenerative disorder, affecting over 100,000 Canadians. With advances in medical and surgical treatments, clients are living longer and fuller lives. However, as the disease progresses those with Parkinson's continue to face a variety of deficits in their occupational performance. Although this is the domain of occupational therapists, very little is described in the occupational therapy literature related to Parkinson's. This article addresses this void by describing these deficits and current measurement tools that can be used to evaluate the impact on people living with Parkinson's disease. Although several tools are cited, three tools are recommended for an occupational therapy evaluation of individuals with Parkinson's disease: the Canadian Occupational Performance Measure, the Unified Parkinson's Disease Rating Scale and the Parkinson's Disease Questionnaire.
AarslandD.LarsenJ.LimN.JanvinC.KarlsenK.TandbergE.CummingsJ. (1999). Range of neuropsychiatric disturbances in patients with Parkinson's disease. Journal of. Neurology Neurosurgery and Psychiatry, 67, 492–496.
2.
BeattieA.CairdF. (1980). The occupational therapist and the patient with Parkinson's disease. British Medical Journal, 280, 1354–1355.
3.
BowlingA, (1997) Measuring Health A Review of Quality of Life Measurement Scales. 2nd edition. Open University Press. Philadelphia.
4.
CalneS.SchulzerM.MakE.GuyetteC.RohsG.HatchardS.MurphyD.HodderJ.GagnonC.WeatherbyS.BeaudetL.DuffJ.PeglerS. (1996). Validating a quality of life scale for idiopathic Parkinsonism: Parkinson's Impact Measurement Scale (PIMS). Parkinsonism & Related Disorders, 2, 55–61.
5.
Canadian Association of Occupational Therapists. (1997). Enabling Occupation: An Occupational Therapy Perspective. Ottawa: CAOT Publications ACE.
6.
CanterG.De La TorreR.MierM. (1961). A method for evaluating disability in patients with Parkinson's disease. Journal of Nervous and Mental Disease, 133, 143–147.
7.
ChouinardG.Ross-ChouinardA.AnnableL.JonesB. (1980). Extrapyramidal Symptom Rating Scale. Canadian Journal of Neurological Sciences, 7, 233.
8.
CleevesL.FindleyJ.GrestyM. (1987). Assessment of Resting Tremor in Parkinson's Disease. In YahrM. & BergmannK. (Eds.), Advances in Neurology Volume 45 Parkinson's Disease. (pp. 349–351). New York: Raven Press Books.
9.
CutsonT.LaubK.SchenkmanM. (1995). Pharmacological and nonpharmacological interventions in the treatment of Parkinson's disease. Physical Therapy, 75, 363–373.
10.
DavisJ., (1977). Team management of Parkinson's disease. The American Journal of Occupational Therapy, 31, 300–308.
11.
deBoerA.WilkerW.SpeelmanJ.deHaeaJ. (1996). Quality of life in patients with Parkinson's disease: development of a questionnaire. Journal of Neurology, Neurosurgery and Psychiatry, 61, 70–74.
12.
DiamondS.MarkhamC. (1983). Evaluating the evaluations: Or how to weigh the scales of parkinsonian disability. Neurology, 33, 1098–1099.
13.
EnglandA.SchwabR. (1956). Postoperative medical evaluation of 26 selected patients with Parkinson's disease. Journal of American Geriatric Society, 4, 1219–1232.
14.
EverittB.HandD.BarrieM. (1989). Bromocriptine in Parkinson's disease: A double-blind study comparing “low-slow” and “high-fast” introductory dosade regimens in de novo patients. Journal of Neurology, Neurosurgery and Psychiatry, 52, 77–82.
15.
FahnS. (1995). Parkinonism. In: RowlandL. P., (Ed.), Merritt's Textbook of Neurology. (9th ed., pp. 713–730). Baltimore: Williams & Wilkins.
16.
FahnS.EltonR.L. and members of the UPDRS committee (1987). Unified Parkinson's disease rating scale. In: FahnS., MarsdenC., GolsteinM. and CalneD. B. (Eds.) Recent Developments in Parkinsons Disease (2nd ed., pp. 153–163), New York: MacMillan.
17.
FieldsJ.TrosterA. (2000). Cognitive outcomes after deep brain stimulation for Parkinson's disease: A review of initial studies and recommendations for future research. Brain and Cognition, 42, 268–293.
18.
FisherA. (1999). Assessment of motor and process skills. (3rd ed.). Fort Collins, Colorado: Three Star Press.
19.
FitzpatrickR.PetoV.JenkinsonC.GreenhallR.HymanN. (1997). Health-related quality of life in Parkinson's disease: A study of outpatient clinic attenders. Movement Disorders, 12, 916–922.
20.
GauthierL.DalzielS.GauthierS. (1987). The benefits of group occupational therapy for patients with Parkinson's disease. The American Journal of Occupational Therapy, 41, 360–365.
21.
GauthierL.GauthierS. (1983). Functional rehabilitation of patient's with Parkinson's disease. Physiotherapy Canada, 35, 220–222.
22.
GeminianiG.CesanaB.TammaF.ContriP.PachettiC.CarellaF.PioltiR.MartignoniE.GiovanniP.GirottiF.CaraceniT. (1991). Interobserver reliability between neurologists in training of Parkinson's disease rating scales: A multicenter study. Movement Disorders, 6, 330–335.
23.
Godwin-AustenR. (1990). Physical Treatments. In SternG. (Ed.), Parkinson's Disease (pp. 647–662). Baltimore: The Johns Hopkins University Press.
24.
GoetzC.WilsonR.TannerC.GarronD. (1987). Relationships Among Pain, Depression, and Sleep Alterations in Parkinson's Disease. In YahrM. & BergmannK. (Eds.), Advances in Neurology Volume 45 Parkinson's Disease. (pp. 345–347). New York: Raven Press Books.
25.
GrowdonJ.CorkinS. (1987). Cognitive Impairments in Parkinson's Disease. In YahrM. & BergmannK. (Eds.), Advances in Neurology Volume 45 Parkinson's Disease. (pp. 383–392). New York: Raven Press Books.
26.
HendersonL.KennardC.CrawfordT.DayS.EverittB.GoodrichS.JonesF.ParkD. (1991). Scales for rating motor impairment in Parkinson's disease: Studies of reliability and convergent validity. Journal of Neurology, Neurosurgery, and Psychiatry, 54, 18–24.
27.
HoehnM.YahrM. (1967). Parkinsonism: Onset, progression, and mortality. Neurology, 17, 427–442.
28.
JenkinsonC.PetoV.FitzpatrickR.GreenhallR.HymanN. (1995). Self-reported functioning and well-being in patients with Parkinson's disease: Comparison of the Short-Form Health Survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39). Age Ageing, 24, 505–509.
29.
LakkeJ. (1990). Assessment and measurement. In SternG. (Ed.), Parkinson's Disease (pp. 467–491). Baltimore: The Johns Hopkins University Press.
30.
LawM. (1993) Evaluating activities of daily living: directions for the future. The American Journal of Occupational Therapy, 47, 233–237.
LawM.LettsL. (1989). A critical review of scales of daily living. American Journal of Occupational Therapy, 43, 522–528.
33.
LawM.PolatajkoH.PollockMcColl M. A.CarswellA.BaptisteS. (1994). Pilot testing of the Canadian Occupational Performance Measure: Clinical and measurement issues. The Canadian Journal of Occupational Therapy, 61, 191–197.
34.
LiebermanA. (1974). Parkinson's disease: A clinical review. The American Journal of the Medical Sciences, 277, 66–80.
35.
LyonsK.PahwaR.TrosterA.KollerW. (1998). A comparison of Parkinson's disease symptoms and self-reported functioning and well being. Parkinsonism and Related Disorders, 3, 207–709.
36.
MansonL.CairdF. (1985) Survey of the hobbies and transport of patients with Parkinson's disease. British Journal of Occupational Therapy, 48, 199–200.
37.
MarkhamC. (1971). The choreoathetoid movement disorder induced by levodopa. Journal of Clinical Pharmacy and Therapeutics, 12, 340–343.
38.
Martinez-MartinP.Gil-NagelA.GraciaM.GomezJ.Martinez-SarriesM.BermejoF., The Cooperative Multicentric Group. (1994). Unified Parkinson's Disease Rating Scale characteristics and structure. Movement Disorder, 9, 76–83.
39.
MathiowetzV. (1993). Role of physical performance component evaluations in occupational therapy functional assessment. The American Journal of Occupational Therapy, 47, 225–230.
40.
MehtaV.SpearsJ.MendezI. (1997). Neural transplantation in Parkinson's disease. Canadian Journal of Neurological Sciences, 24, 292–301.
41.
MorrisM.IansekR. (1997) An interprofessional team approach to rehabilitation in Parkinson's disease. European Journal of Physical Medicine Rehabilitation, 7, 166–170.
42.
MurphyS.Tickle-DegnenL. (2001). The effectiveness of occupational therapy-related treatments for persons with Parkinson's disease: A meta-analytic review. The American Journal of Occupational Therapy, 55, 385–392.
43.
ParkesJ.ZilkhaK.CalverD.Knill-JonesR. (1970). Controlled trial of amantadine hydrochloride in Parkinson's disease. Lancet, 1, 259–262.
44.
PetoV.JenkinsonC.FitzpatrickR.GreenhallR. (1995). The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Quality of Life Research, 241–248.
45.
RichardsM.MarderK.CoteL.MayeuxR. (1994). Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination. Movement Disorders, 9, 89–91.
46.
Saint-CyrJ.TaylorA.NicholsonK. (1995). Behaviour and the Basal Ganglia. In: WeinerW.J. and LangA.E. (Eds.), Behavioural Neurology of Movement Disorders. Advances in Neurology (vol. 65, pp. 1–28).
47.
SchragA.JahanshahiM.QuinnN. (2000). What contributes to quality of life in patients with Parkinson's disease?Journal of Neurology, Neurosurgery and Psychiatry, 69, 308–312.
48.
SelbyG. (1990). Clinical Features. In SternG. (Ed.), Parkinson's Disease (pp. 333–388). Baltimore: The Johns Hopkins University Press.
49.
Straits-TrosterK.FieldsJ.WilkinsonS.PahwaR.LyonsK.KollerW.TrosterA. (2000). Health-related quality of life in Parkinson's disease after pallidotomy and deep brain stimulation. Brain and Cognition, 42, 399–416.
50.
SzaboS. (1996). The World Health Organization Quality of Life (WHOQOL) Assessment Instrument. (1996) In SpilkerB. (Ed.), Quality of Life and Pharmacoeconomics in Clinical Trials, Second Edition. (pp. 355–362). Philadelphia: Lippincott-Raven.
51.
Van HiltenJ.van der ZwanA.ZwindermanA.RoosR. (1994). Rating impairment and disability in Parkinson's diseases: Evaluation of the Unified Parkinson's Disease Rating Scale. Movement Disorders, 9, 84–91.
52.
WatersC. (1998). Diagnosis and Management of Parkinson's Disease. Los Angeles, Ca: Professional Communication.
53.
WebsterD. (1968). Clinical Analysis of the disability in Parkinson's disease. Modern Treatment, 5, 257–82.
54.
WeinerW.SingerC. (1989). Parkinson's disease and nonpharmalogic treatment programs. Journal of the American Geriatric Society37, 359–363.
